Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout
While the vaccine demonstrated high responses for neutralizing influenza A titers, it failed to show sufficient efficacy against influenza B.
While the vaccine demonstrated high responses for neutralizing influenza A titers, it failed to show sufficient efficacy against influenza B.
What's Your Reaction?
